Clinical Trial Update: Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial on preventing graft-versus-host disease in patients with hematologic malignancies undergoing bone marrow transplant has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Graft Versus Host Disease, Leukemia | Phase 1, Phase 2 | Status: WITHDRAWN